- Home
- Publications
- Publication Search
- Publication Details
Title
MDM2 oligomers: antagonizers of the guardian of the genome
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 48, Pages 6157-6165
Publisher
Springer Nature
Online
2016-04-04
DOI
10.1038/onc.2016.88
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Overview of MDM2/X-Targeted Therapies
- (2016) Andrew Burgess et al. Frontiers in Oncology
- Targeting the MDM2/MDM4 Interaction Interface as a Promising Approach for p53 Reactivation Therapy
- (2015) Marsha Pellegrino et al. CANCER RESEARCH
- Native PAGE to study the interaction between the oncosuppressor p53 and its protein ligands
- (2015) Anna Lamberti et al. ELECTROPHORESIS
- Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation
- (2015) Jiangge Zheng et al. GENES & DEVELOPMENT
- The MDM2 RING Domain and Central Acidic Domain Play Distinct Roles in MDM2 Protein Homodimerization and MDM2-MDMX Protein Heterodimerization
- (2015) Patrick L. Leslie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p53 in survival, death and metabolic health: a lifeguard with a licence to kill
- (2015) Flore Kruiswijk et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation
- (2015) Liang Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autoinhibition of MDMX by intramolecular p53 mimicry
- (2015) Lihong Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A site-directed mutagenesis study of the MdmX RING domain
- (2014) Olga Egorova et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage
- (2014) Laura A. Tollini et al. CANCER CELL
- Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction
- (2014) Q. Cheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis
- (2014) Xiufang Xiong et al. eLife
- Affinity-based screening of MDM2/MDMX–p53 interaction inhibitors by chemical array: Identification of novel peptidic inhibitors
- (2013) Taro Noguchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Emerging landscape of oncogenic signatures across human cancers
- (2013) Giovanni Ciriello et al. NATURE GENETICS
- MDM2’s social network
- (2013) R Fåhraeus et al. ONCOGENE
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
- (2013) Yong S. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MDMX contains an autoinhibitory sequence element
- (2013) M. Bista et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development
- (2013) Zhuming Zhang et al. ACS Medicinal Chemistry Letters
- Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers
- (2012) Pavlina Dolezelova et al. CELL CYCLE
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells
- (2012) M Wade et al. ONCOGENE
- Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization
- (2012) B. Graves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The evolution of MDM2 family genes
- (2011) Jamil Momand et al. GENE
- Validation of MdmX as a therapeutic target for reactivating p53 in tumors
- (2011) D. Garcia et al. GENES & DEVELOPMENT
- MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination
- (2011) Xinjiang Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage
- (2011) Q. Cheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Abnormal MDMX degradation in tumor cells due to ARF deficiency
- (2011) X Li et al. ONCOGENE
- Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
- (2011) M H Aziz et al. ONCOGENE
- Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
- (2011) V. Pant et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
- (2011) L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
- (2011) M Michaelis et al. Cell Death & Disease
- Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay
- (2011) A. G. Herman et al. Cancer Discovery
- p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors
- (2010) Baozong Li et al. CELL CYCLE
- HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of theHDMXGene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity
- (2010) Anna Phillips et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase
- (2010) Saravanakumar Iyappan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The p53 orchestra: Mdm2 and Mdmx set the tone
- (2010) Mark Wade et al. TRENDS IN CELL BIOLOGY
- ATM activates p53 by regulating MDM2 oligomerization and E3 processivity
- (2009) Qian Cheng et al. EMBO JOURNAL
- Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase
- (2009) Koji Okamoto et al. FEBS LETTERS
- Inhibitors of MDM2 and MDMX: a structural perspective
- (2009) Christiane Riedinger et al. Future Medicinal Chemistry
- Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans
- (2008) K Linke et al. CELL DEATH AND DIFFERENTIATION
- c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53
- (2008) Valentina Zuckerman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now